Company intelligence / Profile preview

Chenghe Group

Ownership: Private
Development stage: Other

Overview

Chenghe Group is an active global investment holding company based in Singapore and Hong Kong. It focuses on investments and advisory services across TMT (technology/media/telecom), healthcare/biotech/pharma, consumer sectors, and other new economic industries. The firm is known for sponsoring several high-profile SPACs targeting innovative growth companies in Asia-Pacific—including those in biotechnology—and has been involved with IPOs or early-stage investments in major life science firms such as WuXi Biologics.

Modalities: Small moleculeBiologicMonoclonal antibody
Industry: Investors

Partnerships

Partner of Wealthking Investment (HKEx:1140)Co-founder of CSOP Asset Management Limited

Beyond the preview

Go deeper on Chenghe Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chenghe Group.

Explore the full profile